About Factor Bioscience
Factor Bioscience is a company based in Cambridge (United States) founded in 2011 by Christopher Rohde. Factor Bioscience has raised $1 million across 4 funding rounds from investors including HHS and SBIR. Factor Bioscience operates in a competitive market with competitors including Senti Biosciences, Arbor Biotechnologies, Tenaya Therapeutics, Singleron and Bluebird Bio, among others.
- Headquarter Cambridge, United States
- Founders Christopher Rohde
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1 M (USD)
in 4 rounds
-
Latest Funding Round
$1 M (USD), Seed
Sep 15, 2025
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Factor Bioscience
Unlock access to complete
Unlock access to complete
Funding Insights of Factor Bioscience
Factor Bioscience has successfully raised a total of $1M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $1 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Seed — $1.0M
-
First Round
First Round
(17 Sep 2012)
- Investors Count 2
Investments & Acquisitions by Factor Bioscience
Financial Statements - Factor Bioscience
Factor Bioscience Comparisons
Competitors of Factor Bioscience
Factor Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Senti Biosciences, Arbor Biotechnologies, Tenaya Therapeutics, Singleron and Bluebird Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell-based therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Genomic technologies and drug discovery platforms are provided.
|
|
| domain | founded_year | HQ Location |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| domain | founded_year | HQ Location |
Developer of single-cell multi-omics platform for clinical research and molecular diagnosis
|
|
| domain | founded_year | HQ Location |
Gene therapies for severe genetic and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for chronic diseases by targeting mast cells and stem cells
|
Latest news on Factor Bioscience
Frequently Asked Questions about Factor Bioscience
Factor Bioscience was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Factor Bioscience is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Factor Bioscience is a funded company, having raised a total of $1M across 4 funding rounds to date. The company's 1st funding round was a Grant of $79.2K, raised on Sep 17, 2012.
Factor Bioscience was founded in 2011 in Cambridge, United States, within the biotechnology sector. Gene-editing and cell-reprogramming technologies are utilized to generate clonal lines of pluripotent stem cells and advance regenerative cell therapies. Disease-focused approaches are applied to address cancer, genetic disorders, infectious conditions, and degenerative diseases through targeted treatments. Operations emphasize innovation in genomic applications for health improvement.
Factor Bioscience's top competitors include Senti Biosciences, Arbor Biotechnologies and Tenaya Therapeutics.